RAPT Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 11/13/2024 | 5.24 M | $10.52 M | 0.00% | 13.46% |
VANGUARD GROUP INC | 11/13/2024 | 3.16 M | $6.34 M | 1.54% | 8.11% |
COLUMN GROUP LLC | 11/14/2024 | 2.68 M | $5.39 M | 0.00% | 6.89% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.50 M | $5.02 M | 100.00% | 6.42% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2024 | 1.73 M | $3.47 M | 0.00% | 4.43% |
D. E. SHAW & CO., INC. | 11/14/2024 | 1.05 M | $2.11 M | 15.51% | 2.69% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 959,965 | $1.93 M | -6.26% | 2.47% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 842,157 | $1.69 M | 80.26% | 2.16% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 705,000 | $1.42 M | 0.95% | 1.81% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 683,179 | $1.37 M | -0.22% | 1.76% |
STATE STREET CORP | 11/14/2024 | 679,508 | $1.37 M | 1.15% | 1.75% |
EUCLIDEAN CAPITAL LLC | 11/14/2024 | 657,899 | $1.32 M | 0.00% | 1.69% |
ALPHABET INC. | 11/08/2024 | 540,270 | $1.09 M | 0.00% | 1.39% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 525,221 | $1.06 M | -25.74% | 1.35% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 520,422 | $1.05 M | -15.01% | 1.34% |
PALE FIRE CAPITAL SE | 11/12/2024 | 510,724 | $1.03 M | 3,078.12% | 1.31% |
REDMILE GROUP, LLC | 11/14/2024 | 504,532 | $1.01 M | -5.99% | 1.30% |
CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 496,750 | $998,468 | 0.00% | 1.28% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 397,753 | $799,484 | 6.41% | 1.02% |
SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 315,000 | $633,150 | 0.00% | 0.81% |
MORGAN STANLEY | 11/14/2024 | 307,236 | $617,544 | -73.94% | 0.79% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 299,531 | $602,058 | 230.40% | 0.77% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 294,600 | $592,146 | 44.48% | 0.76% |
OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 292,000 | $586,920 | 0.00% | 0.75% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 254,054 | $510,533 | -23.45% | 0.65% |
WOODLINE PARTNERS LP | 11/14/2024 | 236,990 | $476,350 | 42.78% | 0.61% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 201,439 | $404,892 | 138.15% | 0.52% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 175,776 | $355,000 | -15.69% | 0.45% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 154,625 | $310,796 | 0.00% | 0.40% |
WALLEYE CAPITAL LLC | 11/14/2024 | 101,163 | $203,338 | -12.64% | 0.26% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 90,209 | $181,320 | -21.28% | 0.23% |
EXCHANGE TRADED CONCEPTS, LLC | 10/10/2024 | 89,076 | $179,043 | 244.71% | 0.23% |
NOMURA HOLDINGS INC | 11/14/2024 | 84,184 | $169,210 | 100.00% | 0.22% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 77,709 | $156,195 | 0.00% | 0.20% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 75,000 | $150,750 | 100.00% | 0.19% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 71,449 | $143,612 | -34.90% | 0.18% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 70,946 | $142,601 | -65.91% | 0.18% |
JANE STREET GROUP, LLC | 11/15/2024 | 66,515 | $133,696 | -66.91% | 0.17% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 55,520 | $111,595 | -81.20% | 0.14% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 50,710 | $101,927 | 0.00% | 0.13% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2024 | 47,927 | $96,333 | -1.23% | 0.12% |
ALGERT GLOBAL LLC | 11/12/2024 | 47,483 | $95,000 | 0.00% | 0.12% |
RHUMBLINE ADVISERS | 11/12/2024 | 46,193 | $92,835 | -0.69% | 0.12% |
JASPER RIDGE PARTNERS, L.P. | 11/14/2024 | 45,650 | $91,756 | 0.00% | 0.12% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 45,050 | $90,551 | 0.00% | 0.12% |
BARCLAYS PLC | 11/19/2024 | 39,729 | $79,000 | 277.15% | 0.10% |
TREXQUANT INVESTMENT LP | 11/12/2024 | 37,955 | $76,290 | -73.71% | 0.10% |
PDT PARTNERS, LLC | 11/14/2024 | 36,998 | $74,366 | -62.17% | 0.10% |
UBS GROUP AG | 11/14/2024 | 28,846 | $57,980 | 0.90% | 0.07% |
CITADEL ADVISORS LLC | 11/14/2024 | 25,600 | $51,456 | -67.47% | 0.07% |
RAPT Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of RAPT Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 5.24 M
VANGUARD GROUP INC: 3.16 M
Column Group LLC: 2.68 M
BlackRock Funding, Inc. /DE: 2.5 M
KINGDON CAPITAL MANAGEMENT, L.L.C.: 1.73 M
D. E. Shaw & Co., Inc.: 1.05 M
76.60% of RAPT Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 39.51 M shares in the last 24 months. This purchase volume represents approximately $67.17 M in transactions.